262 related articles for article (PubMed ID: 15831437)
1. Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.
Stevens R; Rüsch D; Solt K; Raines DE; Davies PA
J Pharmacol Exp Ther; 2005 Jul; 314(1):338-45. PubMed ID: 15831437
[TBL] [Abstract][Full Text] [Related]
2. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
3. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols.
Rüsch D; Musset B; Wulf H; Schuster A; Raines DE
J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702
[TBL] [Abstract][Full Text] [Related]
4. Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors.
Stevens RJN; Rüsch D; Davies PA; Raines DE
Anesth Analg; 2005 Jun; 100(6):1696-1703. PubMed ID: 15920198
[TBL] [Abstract][Full Text] [Related]
5. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes.
Suzuki T; Koyama H; Sugimoto M; Uchida I; Mashimo T
Anesthesiology; 2002 Mar; 96(3):699-704. PubMed ID: 11873047
[TBL] [Abstract][Full Text] [Related]
6. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
7. Local anesthetics have different mechanisms and sites of action at recombinant 5-HT3 receptors.
Ueta K; Suzuki T; Sugimoto M; Uchida I; Mashimo T
Reg Anesth Pain Med; 2007; 32(6):462-70. PubMed ID: 18035290
[TBL] [Abstract][Full Text] [Related]
8. Alcohols and anesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes.
Machu TK; Harris RA
J Pharmacol Exp Ther; 1994 Nov; 271(2):898-905. PubMed ID: 7965811
[TBL] [Abstract][Full Text] [Related]
9. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
10. The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
Koo BN; Kim MK; Yang J; Min KT
Neurosci Lett; 2009 Nov; 465(2):147-50. PubMed ID: 19765401
[TBL] [Abstract][Full Text] [Related]
11. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine.
Yamakura T; Chavez-Noriega LE; Harris RA
Anesthesiology; 2000 Apr; 92(4):1144-53. PubMed ID: 10754635
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
[TBL] [Abstract][Full Text] [Related]
13. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues involved in agonist binding and its linking to channel gating, proximal to transmembrane domain of 5-HT3A receptor for halothane modulation.
Kim MK; Min KT; Koo BN
Korean J Anesthesiol; 2009 Jan; 56(1):66-73. PubMed ID: 30625697
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of expressed L-type calcium channels and muscarinic M(1) receptors to volatile anesthetics in Xenopus oocytes.
Kamatchi GL; Durieux ME; Lynch C
J Pharmacol Exp Ther; 2001 Jun; 297(3):981-90. PubMed ID: 11356920
[TBL] [Abstract][Full Text] [Related]
16. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
17. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
[TBL] [Abstract][Full Text] [Related]
18. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
Stuebler AG; Jansen M
Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics.
Minami K; Minami M; Harris RA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1136-43. PubMed ID: 9190846
[TBL] [Abstract][Full Text] [Related]
20. Intravenous anesthetics differentially modulate ligand-gated ion channels.
Flood P; Krasowski MD
Anesthesiology; 2000 May; 92(5):1418-25. PubMed ID: 10781289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
